Hair loss
Hair loss is a symptom that occurs occasionally in ME/CFS.[1][2] It can also be a symptom of comorbid illnesses such as hypothyroidism, systemic lupus erythematosus and is sometimes found in Long COVID patients.[3] Hair loss can refer to either a hair loss condition such as alopecia areata, where patches of scalp lose all or virtually all hair, or as telogen effluvium, which is a general thinning of hair across the head where hair loss is typically less than 50% of hair.[4][3][5]
Contents
Prevalence[edit | edit source]
The Canadian Consensus Criteria recognizes hair loss as a neuroendocrine system symptom in ME/CFS.[2]
Katrina Berne reports a prevalence of 20-35% for hair loss.[6]
Potential causes[edit | edit source]
- Endocrine changes
- Medication side effecta (e.g. DHEA, Ampligen, Elmiron)
- Lysine deficiency
- Excessive Vitamin A intake
- Excessive selenium intake
- Increase in stress hormones[1]
- Any serious illness can cause telogen effluvium, including COVID-19 and ME/CFS[5][2][3]
Potential treatments[edit | edit source]
- Treatment of comorbid illnesses such as hypothyroidism or systemic lupus erythematosus[5]
- Avoidance of harsh hair products
- B vitamins
- Coenzyme Q10
- Ginkgo biloba
- Inositol[1][7]
Learn more[edit | edit source]
- Alopecia areata - symptoms
- Hair loss - NHS
- Hair loss symptoms and causes - Mayo Clinic
- Understanding Hair Loss: Basics - WebMD
- What causes Telogen Effluvium - WebMD
See also[edit | edit source]
References[edit | edit source]
- ↑ 1.01.11.2 Verrillo, Erica (September 14, 2012). Chronic Fatigue Syndrome: A Treatment Guide (Kindle eBook) (2nd ed.).
- ↑ 2.02.12.2 Carruthers, Bruce M.; Jain, Anil Kumar; De Meirleir, Kenny L.; Peterson, Daniel L.; Klimas, Nancy G.; Lerner, A. Martin; Bested, Alison C.; Flor-Henry, Pierre; Joshi, Pradip; Powles, AC Peter; Sherkey, Jeffrey A.; van de Sande, Marjorie I. (2003), "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols" (PDF), Journal of Chronic Fatigue Syndrome, 11 (2): 7–115, doi:10.1300/J092v11n01_02
- ↑ 3.03.13.2 Hussain, Nabeel; Agarwala, Preeti; Iqbal, Kinza; Omar, Hanaa Mohamed Sheikh; Jangid, Gurusha; Patel, Vraj; Rathore, Sawai Singh; Kumari, Chandani; Velasquez-Botero, Felipe; López, Guadalupe Abigail Benítez; Vishwakarma, Yogesh (2022). "A systematic review of acute telogen effluvium, a harrowing post-COVID-19 manifestation". Journal of Medical Virology. 94 (4): 1391–1401. doi:10.1002/jmv.27534. ISSN 1096-9071.
- ↑ Mieczkowska, Karolina; Deutsch, Alana; Borok, Jenna; Guzman, Anthony K.; Fruchter, Renee; Patel, Parth; Wind, Olivia; McLellan, Beth N.; Mann, Ranon E.; Halverstam, Caroline P. (November 23, 2020). "Telogen effluvium: a sequela of COVID‐19". International Journal of Dermatology: 10.1111/ijd.15313. doi:10.1111/ijd.15313. ISSN 0011-9059. PMC 7753411. PMID 33226117.
- ↑ 5.05.15.2 "What Causes Telogen Effluvium?". WebMD. Retrieved February 20, 2022.
- ↑ Berne, Katrina (December 1, 1995), Running on Empty: The Complete Guide to Chronic Fatigue Syndrome (CFIDS) (2nd ed.), Hunter House, p. 58, ISBN 978-0897931915
- ↑ "Hair loss". National Health Service. October 23, 2017. Retrieved February 20, 2022.
neuroendocrine relating to hormones that influence the nervous system
The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.
